Why the study?
Does E-vapor aerosol inhalation reduce cardiovascular effects compared to conventional cigarette smoke in ApoE-/- mice?
Does E-vapor aerosol inhalation reduce cardiovascular effects compared to conventional cigarette smoke in ApoE-/- mice?
E-vapor aerosols demonstrated significantly reduced cardiovascular toxicity, oxidative stress, and inflammation compared to conventional cigarette smoke in a 6-month ApoE-/- mouse model.
E-vapor aerosols may reduce oxidative stress and atherosclerosis versus cigarette smoke in animals; leaves open human translation and clinical relevance.
Analysis of key urinary oxidative stress markers and proinflammatory cytokines showed an absence of oxidative stress and inflammation in the animals exposed to E-vapor aerosols. Conversely, animals exposed to conventional cigarette smoke had high urinary levels of these markers. When compared with conventional cigarette smoke, E-vapor aerosols induced smaller atherosclerotic plaque surface area and volume. Systolic and diastolic cardiac function, as well as endothelial function, were further significantly less affected by electronic cigarette aerosols than conventional cigarette smoke. Molecular analysis demonstrated that E-vapor aerosols induce significantly smaller transcriptomic dysregulation in the heart and aorta compared with conventional cigarette smoke.
No takes yet. Share an insight, caveat, or question.
Szostak et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: